Roubaix Capital, LLC Cerus Corp Transaction History

Roubaix Capital, LLC

  • $152 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 28, 2022
SELL
$5.97 - $7.93 $3.49 Million - $4.64 Million
-584,753 Closed
0 $0
Q3 2021

Oct 18, 2021
BUY
$4.79 - $6.68 $363,699 - $507,205
75,929 Added 14.92%
584,753 $3.56 Million
Q2 2021

Jul 22, 2021
BUY
$5.35 - $6.35 $2.72 Million - $3.23 Million
508,824 New
508,824 $3.01 Million

Others Institutions Holding CERS

# of Institutions
156
Shares Held
147M
Call Options Held
84.2K
Put Options Held
55.5K
View Full List

About CERUS CORP

CERS Quotes by TradingView
  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $317M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Roubaix Capital, LLC Portfolio

Follow Roubaix Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Roubaix Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Roubaix Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email